PRF Technologies (PRFX) Operating Income (2020 - 2024)
PRF Technologies' (PRFX) quarterly Operating Income came in at -$7.3 million in Q2 2024, down 226.15% YoY from $5.8 million in Q3 2023, and down 31.99% on a QoQ basis from -$5.6 million in Q1 2024.
PRF Technologies (PRFX) Operating Income (2020 - 2024) Analysis & Trends
PRF Technologies (PRFX) has 5 years of Operating Income data on file, last reported at -$7.3 million in Q2 2024.
- Quarterly Operating Income fell 226.15% year-over-year to -$7.3 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$17.8 million (down 77.9% YoY) and the FY2025 annual result came in at -$5.1 million, up 65.09% from the prior year.
- Operating Income slipped to -$7.3 million in Q2 2024, from -$5.6 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$132000.0 in Q1 2020 to a low of -$7.3 million in Q2 2024.
- A 5-year average of -$2.2 million and a median of -$1.8 million in 2021 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2021 — Operating Income slumped 1444.7% — and 2023, when it surged 35.5%.
- Tracing PRFX's Operating Income over 5 years: stood at -$691000.0 in 2020, then plunged by 151.95% to -$1.7 million in 2021, then slumped by 87.02% to -$3.3 million in 2022, then decreased by 9.46% to -$3.6 million in 2023, then sank by 106.09% to -$7.3 million in 2024.
- The last three Operating Income figures came in at -$7.3 million (Q2 2024), -$5.6 million (Q1 2024), and -$3.6 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | PRF Technologies | 644,409.14 | -3.50 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -7.35 Mn |
| Mar 31, 2024 | -5.57 Mn |
| Dec 31, 2023 | -3.56 Mn |
| Sep 30, 2023 | -1.35 Mn |
| Jun 30, 2023 | -2.25 Mn |
| Mar 31, 2023 | -2.42 Mn |
| Dec 31, 2022 | -3.26 Mn |
| Sep 30, 2022 | -2.10 Mn |
| Jun 30, 2022 | -1.85 Mn |
| Mar 31, 2022 | -1.67 Mn |
| Dec 31, 2021 | -1.74 Mn |
| Sep 30, 2021 | -1.77 Mn |
| Jun 30, 2021 | -1.66 Mn |
| Mar 31, 2021 | -2.04 Mn |
| Dec 31, 2020 | -691,000.00 |
| Sep 30, 2020 | -700,000.00 |
| Jun 30, 2020 | -148,000.00 |
| Mar 31, 2020 | -132,000.00 |